BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 5698887)

  • 1. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.
    Thomssen R; Bonk S; Thiele A
    Med Microbiol Immunol; 1993 Dec; 182(6):329-34. PubMed ID: 8121333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on rubella virus hemagglutination. I. Activation by various treatments.
    Sato H
    Arch Gesamte Virusforsch; 1971; 35(2):256-68. PubMed ID: 5002908
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the substructure of togaviruses. II. Analysis of equine arteritis, rubella, bovine viral diarrhea, and hog cholera viruses.
    Horzinek M; Maess J; Laufs R
    Arch Gesamte Virusforsch; 1971; 33(3):306-18. PubMed ID: 4107033
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of hepatitis C virus in human sera with beta-lipoprotein.
    Thomssen R; Bonk S; Propfe C; Heermann KH; Köchel HG; Uy A
    Med Microbiol Immunol; 1992; 181(5):293-300. PubMed ID: 1335546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of non-specific serum inhibitors of haemagglutination of rubella virus by treatment with dodecylamine-gel.
    Ho WK; Shortridge KF
    J Clin Pathol; 1976 Nov; 29(11):995-8. PubMed ID: 1002845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of rubella virus hemagglutination. I. Properties of an inhibitor of rubella virus hemagglutination in vitro present in fetal calf serum].
    Laufs R; Thomssen R
    Arch Gesamte Virusforsch; 1968; 24(3):181-91. PubMed ID: 5698887
    [No Abstract]   [Full Text] [Related]  

  • 7. Rubella haemagglutination inhibitors: their separation from antibodies.
    Haukenes G; Aasen J
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(5):679-85. PubMed ID: 5286216
    [No Abstract]   [Full Text] [Related]  

  • 8. Physical and immunologic properties of rubella antigens.
    Schmidt NJ; Lennette EH; Gee PS; Dennis J
    J Immunol; 1968 Apr; 100(4):851-7. PubMed ID: 5645224
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of rivanol for the removal of nonspecific inhibitors of rubella virus haemagglutinin.
    Toms GL; Mostratos A
    J Med Microbiol; 1973 Feb; 6(1):45-52. PubMed ID: 4347864
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple and rapid method for detection of serum IgM antibodies to the rubella virus hemagglutinin.
    Traavik T
    J Virol Methods; 1982 Jan; 3(6):337-47. PubMed ID: 7085839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of gel precipitating antigens of rubella virus.
    Salmi AA
    Arch Gesamte Virusforsch; 1970; 32(2):91-8. PubMed ID: 4993576
    [No Abstract]   [Full Text] [Related]  

  • 12. The carbohydrate of gamma-globulin and myeloma proteins.
    MULLER-EBERHARD HJ; KUNKEL HG
    J Exp Med; 1956 Aug; 104(2):253-69. PubMed ID: 13345970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubella-virus hemagglutination-inhibition test.
    Stewart GL; Parkman PD; Hopps HE; Douglas RD; Hamilton JP; Meyer HM
    N Engl J Med; 1967 Mar; 276(10):554-7. PubMed ID: 6019765
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.